Literature DB >> 21750292

Use of intravenous neuraminidase inhibitors during the 2009 pandemic: results from population-based surveillance.

Alicia M Fry1, Alejandro Pérez, Lyn Finelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21750292     DOI： 10.1001/jama.2011.950

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

Review 1.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

2.  Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09.

Authors:  Janice K Louie; Samuel Yang; Cynthia Yen; Meileen Acosta; Robert Schechter; Timothy M Uyeki
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

Review 3.  Safety and efficacy of peramivir for influenza treatment.

Authors:  Atsuko Hata; Ryoko Akashi-Ueda; Kazufumi Takamatsu; Takuro Matsumura
Journal:  Drug Des Devel Ther       Date:  2014-10-24       Impact factor: 4.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.